Modulation of the gut microbiota is one of the promising tools to tackle obesity. Chang and colleagues have recently shown that an extract of the mushroom Ganoderma lucidum, a traditional remedy in Asia, can reduce obesity in mice by modulating the gut microbiota, thereby exerting a prebiotic effect.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Assessment of Polysaccharides from Mycelia of genus Ganoderma by Mid-Infrared and Near-Infrared Spectroscopy
Scientific Reports Open Access 08 January 2018
-
Resistant starch can improve insulin sensitivity independently of the gut microbiota
Microbiome Open Access 07 February 2017
-
Cultivation of mushrooms for production of food biofortified with lithium
European Food Research and Technology Open Access 26 November 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Bindels, L. B., Delzenne, N. M., Cani, P. D. & Walter, J. Towards a more comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 12, 303–310 (2015).
Chang, C. J. et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat. Commun. 6, 7489 (2015).
Klupp, N. L. et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database of Systematic Reviews Issue 2. Art. No.: CD007259 http://dx.doi.org/10.1002/14651858.CD007259.pub2.
Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1762 (2007).
Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481 (2008).
Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509–1517 (2009).
Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337–341 (2011).
Kuipers, F., Bloks, V. W. & Groen, A. K. Beyond intestinal soap—bile acids in metabolic control. Nat. Rev. Endocrinol. 10, 488–498 (2014).
Salonen, A. et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME. J. 8, 2218–2230 (2014).
Dao, M. C. et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut http://dx.doi.org/10.1136/gutjnl-2014-308778.
Acknowledgements
N.M.D. is a recipient of IWT subsidies and grants from the FRS-FNRS, the Walloon Region and the European Union's Seventh Framework Program community. L.B.B. is a postdoctoral fellow from the FRS-FNRS.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Delzenne, N., Bindels, L. Ganoderma lucidum, a new prebiotic agent to treat obesity?. Nat Rev Gastroenterol Hepatol 12, 553–554 (2015). https://doi.org/10.1038/nrgastro.2015.137
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2015.137
This article is cited by
-
Role of edible mushroom as a potent therapeutics for the diabetes and obesity
3 Biotech (2019)
-
Connection between gut microbiome and the development of obesity
European Journal of Clinical Microbiology & Infectious Diseases (2019)
-
Assessment of Polysaccharides from Mycelia of genus Ganoderma by Mid-Infrared and Near-Infrared Spectroscopy
Scientific Reports (2018)
-
Resistant starch can improve insulin sensitivity independently of the gut microbiota
Microbiome (2017)
-
Anti-obesogenic and antidiabetic effects of plants and mushrooms
Nature Reviews Endocrinology (2017)
